Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients

BMC Gastroenterology

Volumn 3, Issue , 2003, Pages

  Bahrami, Hossein ^a   Daryani, Nasser Ebrahimi ^a   Mirmomen, Shahram ^a   Kamangar, Farin ^a   Haghpanah, Babak ^a   Djalili, Mehdi ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE;

ADULT; ALCOHOL CONSUMPTION; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE MARKER; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; HISTOPATHOLOGY; HUMAN; INFLAMMATION; IRAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; NONALCOHOLIC FATTY LIVER; OBESITY; RISK FACTOR; SEROLOGY; VIRUS HEPATITIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; BIOPSY; CHRONIC DISEASE; COMORBIDITY; DIABETES MELLITUS; FAT NECROSIS; FATTY LIVER; FEMALE; HEPATITIS; HUMANS; HYPERLIPIDEMIAS; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; IRAN; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; OBESITY; RISK FACTORS; SEX DISTRIBUTION;

EID: 2442647734     PISSN: 1471230X     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-3-27     Document Type: Article

References (39)

1. Sheth SG, Gordon FD and Chopra S: Nanalcoholic steatohepatitis. Ann Intern Med 1997, 126:137-45.
2. Brunt EM, Janney CG and Di Bisceglie AM et al.: Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999, 94:2467-74.
3. Clark JM, Brancati FL and Diehl AM: Nonalcoholic fatty liver disease. Gastroenterology 2002, 122:1649-57.
4. Flack-ytter Y, McCullough AJ and Younossi Z et al.: Clinical features and natural history of Nonalcoholic Steatosis Syndromes. Sem Liver Disease 2001, 21:17-26.
5. Kumar KS and Malet PF: Nonalcoholic steatohepatitis. Mayo Clin Proc 2000, 75:733-39.
6. Angulo P: Nanalcoholic fatty liver disease. N Engl J Med 2002, 346:1221-31.
7. Reid AE: Nonalcoholic steatohepatitis. Gastroenterology 2001, 121:710-723.
8. Matteoni C, Younossi ZM and McCullough A: Nonalcoholic fatty liver disease:A spectrum of clinical pathological severity. Gastroenterology 1999, 116:1413-19.
9. Bacon B, Faravash MJ and Janney CG et al.: Nonalcoholic steatohepatitis: An expanded clinical entity. Gastroenterology 1994, 107:1103-6.
10. Powell EE, Cooksley GE and Hanson R et al.: The natural history of nonalcoholic steatohepatitis: A follow-up study of 42 patients for up to 21 years. Hepatology 1990, 11:74-80.
11. Lee RG: Nonalcoholic steatohepatitis: A study of 49 patients. Hum Pathol 1989, 11:594-8.
12. Ludwig J, Viggiono TR and McGill DB et al.: Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980, 55:342-8.
13. Propst A, Propst T and Judmaei G et al.: Prognosis in nonalcoholic steatohepatitis (letter). Gastroenterology 1995, 108:1607.
14. el-Hassan AY, Ibrahim EM and al-Milhim FA et al.: Fatty infiltration of the liver: analysis of prevalence, radiological and clinical features and influence on patient management. Br J Radiol 1992, 65:774-8.
15. Nonomura A, Mizukami Y and Unoura M et al.: Clinicopathologic study of alcohol-like liver disease in non-alcoholics; Nonalcoholic steatohepatitis and fibrosis. Gastroenterol Jpn 1992, 27:521.
16. Baldrige AD, Perez-Atayde AR and Graeme-Cook F et al.: Idiopathic steatohepatitis in childhood: A multicenter retrospective study. J Pediatr 1995, 127:700.
17. Moran JR, Ghishan FK and Halter SA et al.: Steatohepatitis in obese children: A cause of chronic liver dysfunction. Am J Gastroenterol 1983, 78:374.
18. Wanless IR and Lentz JS: Fatty liver hepatitis (Steatohepatitis) and obesity: An autopsy study with analysis of risk factors. Hepatology 1990, 12:1106.
19. Itoh S, Yougel T and Kawagoe K: Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis. Am J Gastroenterol 1987, 82:650.
20. Diehl AM, Goodman Z and Ishak KG: Alcohol-like disease in nonalcoholics. Gastroenterology 1988, 95:1056.
21. Pinto HC, Baptista A and Camilo ME et al.: Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients. Dig Dis Sci 1996, 41:172.
22. Hamwi GJ: Therapy: Changing dietary needs. In: Diabetes Mellitus: Diagnosis and Treatment Edited by: Danowski TS. New York, NY, American Diabetes Association; 1964:73-78.
23. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-97.
24. Cello JP and Grendell JH: The liver in systemic conditions. In: Hepatology Edited by: Zakim D, Boyer TD. Philadelphia, WB Saunders; 1990:1428.
25. Capron JP, Delamarre M and Dupas JL et al.: Fasting in obesity: another cause of liver injury with alcoholic hyaline? Dig Dis Sci 1982, 54:374-7.
26. Adler M and Schaffner F: Fatty liver hepatitis and cirrhosis in obese patients. Am J Med 1979, 67:811-9.
27. Sorbi D, Boynton J and Lindor KD: The ratio of aspartate aminotransferase to alanine aminotransferase: Potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am J Gastroenterol 1999, 94:1018.
28. Cohen JA and Kaplan MM: The SGOT/SGPT ratio - an indicator of alcoholic liver disease. Dig Dis Sci 1979, 24:835.
29. Lonardo A, Bellini M and Tondelli E et al.: Nonalcoholic steatohepatitis and the "bright liver syndrome": Should a recently expanded clinical entity be further expanded? Am J Gastroenterol 1995, 90:2072.
30. Van Ness MM and Diehl AM: Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes? Ann Intern Med 1989, 111:473.
31. James OF and Day CP: Nonalcoholic steatohepatitis (NASH): a disease of emerging identity and importance. J Hepatol 1998, 29:495-501.
32. Neuschwander-Tetri BA and Bacon BR: Nonalcoholic steatohepatitis. Med Clin North Am 1996, 80:1147-66.
33. Nomura F, Ohnishi K and Ochiai T et al.: Obesity-related Nonalcoholic fatty liver:CT features and follow-up studies after low-calorie diet. Radiology 1987, 162:845-7.
34. Acosta D and Wenzel DG: Injury produced by free fatty acids to lysosomes and mitochondria in cultured heart muscle and endothelial cells. Atherosclerosis 1974, 20:417.
35. Dianzani MU: Hepatotoxicology. In: Biochemical aspects of fatty liver Edited by: Meeks RG, Harrison SD, Bull RJ. Boca Raton, CRC; 1991:327.
36. Lombardi B: Fatty liver: Considerations on the pathogenesis of fatty liver. Lab Invest 1966, 15:1.
37. Cortez-Pinto H, Chatham J and Chacko VP et al.: Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: A pilot study. JAMA 1999, 282:1659.
38. Berson AD, Beco V and Lettetan P et al.: Steatohepatitis-inducing drugs cause mitochondrial dysfunction of lipids peroxidation in rat hepatocytes. Gastroenterology 1998, 114:764.
39. Falk-ytter Y, McCullough AJ and Younossi J et al.: Clinical features and natural history of nonalcoholic steatosis syndromes. Sem Liver Disease 2001, 21:17-26.